Impro Precision Industries (1286) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
11 Aug, 2026Executive summary
Group revenue rose 23.2% year-over-year to HK$3,018.0M for 1H/2026, driven by strong demand in AI-related, data centers, energy, and diversified industrials end-markets.
Profit attributable to shareholders increased 21.6% to HK$421.0M; adjusted profit up 20.4% to HK$433.1M; EBITDA rose 15.8% to HK$828.4M.
Gross profit margin improved by 0.6 percentage points to 28.4%, with notable gains in the high horsepower engine segment.
Operating cash flow increased 24.1% to HK$689.1M, supporting a stable interim dividend of HK$0.08/share.
Challenges included losses at the Mexico SLP Campus due to ramp-up costs and Turkish plant profit decline from inflation and weak European auto demand.
Financial highlights
Revenue by end-market: Diversified Industrials up 38.7%, Energy up 83.7%, Aerospace up 34.6%, Recreational Boat & Vehicle up 57.4%.
Americas accounted for 48.4% of revenue, Asia 27.9% (up 50.9%), Europe 23.7% (down 2.3%).
EBITDA margin at 27.4%; adjusted EPS increased 19.4% to 22.8 HK cents.
Market capitalization surged 70.1% to HK$15,636.7M; net debt reduced by 26.6%.
Adjusted return on equity at 13.4%; net gearing ratio at 18.3%.
Outlook and guidance
Full-year 2026 sales growth forecast raised to 20–25% year-over-year, supported by strong order backlog, AI infrastructure, and new project development.
Anticipated acceleration in sales growth in 2H/2026, driven by ramp-up at Mexico SLP Campus and robust AI-related demand.
Mexico SLP Campus expected to enter mass production in H2 2026, supporting North American expansion.
Ample liquidity with ~HK$1.2B cash and HK$2.6B undrawn banking facilities to support expansion and potential M&A.
Targeting to double total revenue to over HK$10 billion by 2029/2030.
Latest events from Impro Precision Industries
- Record profit and revenue growth led by medical and AI sectors, with strong outlook and robust cash flow.1286
H2 2025 - Adjusted profit rose 11.6% on 2.0% revenue growth, led by high horsepower engine and medical segments.1286
H1 2025 - Adjusted profit up 3.6% on stable revenue, led by high horsepower engine and aerospace growth.1286
H1 2024 - High horsepower engine and aerospace drove profit and margin growth, with robust 2025 outlook.1286
H2 2024